{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:56:46Z","timestamp":1787061406711,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hfc.2024.12.004","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T07:45:06Z","timestamp":1738914306000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Viability and Congestive Heart Failure"],"prefix":"10.1016","volume":"21","author":[{"given":"Mehmet","family":"Onur Omaygenc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Marie","family":"Mielniczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2024.12.004_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib2","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2024.12.004_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4330\/wjc.v9.i5.407","article-title":"Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: mechanisms, incidence and identification of patients at risk","volume":"9","author":"Cahill","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101215","article-title":"Heart failure after ST-elevation myocardial infarction: beyond left ventricular adverse remodeling","volume":"48","author":"Del Buono","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11886-017-0876-4","article-title":"Adverse remodeling and reverse remodeling after myocardial infarction","volume":"19","author":"Bhatt","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hfc.2024.12.004_bib6","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib7","article-title":"Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how","volume":"12","author":"Liga","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hfc.2024.12.004_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cjca.2019.04.029","article-title":"The current role of viability imaging to guide revascularization and therapy decisions in patients with heart failure and reduced left ventricular function","volume":"35","author":"Kandolin","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/HCO.0000000000000651","article-title":"Myocardial viability: heart failure perspective","volume":"34","author":"Bock","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCHEARTFAILURE.113.000912","article-title":"Molecular and cellular basis of viable dysfunctional myocardium","volume":"7","author":"Bayeva","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2024.12.004_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jacc.2021.07.004","article-title":"Myocardial viability assessment before surgical revascularization in ischemic cardiomyopathy: JACC review topic of the week","volume":"78","author":"Panza","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2014.11.040","article-title":"Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia","volume":"65","author":"Page","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCRESAHA.107.155895","article-title":"Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium","volume":"102","author":"Page","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2024.12.004_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/HCI.0000000000000053","article-title":"State of the art: imaging for myocardial viability: a scientific statement from the American heart association","volume":"13","author":"Garcia","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.12.004_bib15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.004_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial viability and long-term outcomes in ischemic cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11886-020-01433-8","article-title":"Multimodality imaging of myocardial viability","volume":"23","author":"Parikh","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hfc.2024.12.004_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/clc.23779","article-title":"Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy","volume":"45","author":"Katikireddy","year":"2022","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cpcardiol.2007.04.001","article-title":"Hibernating myocardium: diagnosis and patient outcomes","volume":"32","author":"Schinkel","year":"2007","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jcmg.2012.02.009","article-title":"CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials","volume":"5","author":"Romero","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.12.004_bib21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00525-8","article-title":"End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest redistribution T1-201 tomography and dobutamine stress echocardiography","volume":"35","author":"Cwajg","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/jama.2013.1381","article-title":"Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease","volume":"309","author":"Shah","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2024.12.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2019.07.001","article-title":"Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American Society of Echocardiography","volume":"33","author":"Pellikka","year":"2020","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2024.12.004_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ejechocard\/jeq062","article-title":"Resting myocardial blood flow, coronary flow reserve, and contractile reserve in hibernating myocardium: implications for using resting myocardial contrast echocardiography vs. dobutamine echocardiography for the detection of hibernating myocardium","volume":"11","author":"Hickman","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.hfc.2024.12.004_bib25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/medicina58101429","article-title":"Long-term prognostic value of myocardial viability by myocardial contrast echocardiography in patients after acute myocardial infarction: a systematic review and meta-analysis","volume":"58","author":"Wang","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.hfc.2024.12.004_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.echo.2013.11.014","article-title":"Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance","volume":"27","author":"Altiok","year":"2014","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2024.12.004_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168349","article-title":"Prediction of left ventricular remodeling after a myocardial infarction: role of myocardial deformation: a systematic review and meta-analysis","volume":"11","author":"Huttin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.hfc.2024.12.004_bib28","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/01.CIR.0000128862.34201.74","article-title":"Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery","volume":"109","author":"Wellnhofer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.12.004_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.acra.2019.03.021","article-title":"Assessment of myocardial viability in ischemic heart disease by PET\/MRI: comparison of left ventricular perfusion, hibernation, and scar burden","volume":"27","author":"Beitzke","year":"2020","journal-title":"Acad Radiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10741-020-09975-3","article-title":"Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade","volume":"27","author":"Legallois","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2024.12.004_bib31","first-page":"334","article-title":"Left ventricular adverse remodeling in ischemic heart disease: emerging cardiac magnetic resonance imaging biomarkers","volume":"12","author":"Calvieri","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jmri.28499","article-title":"Manganese-enhanced magnetic resonance imaging of the heart","volume":"57","author":"Singh","year":"2023","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.hfc.2024.12.004_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199007193230301","article-title":"Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging","volume":"323","author":"Dilsizian","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers","volume":"23","author":"Henzlova","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib35","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(97)00061-2","article-title":"Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201","volume":"29","author":"Matsunari","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib36","series-title":"Nuclear cardiology","first-page":"128","article-title":"Radiopharmaceuticals used in myocardial perfusion scintigraphy","author":"Sabharwal","year":"2017"},{"key":"10.1016\/j.hfc.2024.12.004_bib37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib38","first-page":"200","article-title":"Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation","volume":"8","author":"Davidson","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.hfc.2024.12.004_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1067\/mcd.2001.109973","article-title":"Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium","volume":"26","author":"Bax","year":"2001","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0735-1097(00)01087-1","article-title":"No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium","volume":"37","author":"Siebelink","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/hrt.79.3.281","article-title":"Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure","volume":"79","author":"Pagano","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2024.12.004_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.echo.2005.10.024","article-title":"Automated quantification of the spatial extent of perfusion defects and viability on myocardial contrast echocardiography","volume":"19","author":"Micari","year":"2006","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2024.12.004_bib43","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1007\/s00330-023-09394-6","article-title":"Radiomics-based machine learning models in STEMI: a promising tool for the prediction of major adverse cardiac events","volume":"33","author":"Durmaz","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib44","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abe225","article-title":"Low-dose PET image noise reduction using deep learning: application to cardiac viability FDG imaging in patients with ischemic heart disease","volume":"66","author":"Ladefoged","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.hfc.2024.12.004_bib45","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.cjca.2017.06.012","article-title":"N-terminal pro B-type natriuretic peptide and high-sensitivity cardiac Troponin T levels are related to the extent of hibernating myocardium in patients with ischemic heart failure","volume":"33","author":"Zelt","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib47","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0735-1097(97)00352-5","article-title":"Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data","volume":"30","author":"Bax","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib48","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib49","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib50","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib51","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib52","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib53","article-title":"Long-term follow-up of outcomes with F-18-Fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease","volume":"9","author":"Mc","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.12.004_bib54","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jcmg.2009.02.017","article-title":"Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial","volume":"2","author":"D'Egidio","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.12.004_bib55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2967\/jnumed.109.065938","article-title":"18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial","volume":"51","author":"Abraham","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.hfc.2024.12.004_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2015.03.152","article-title":"Long-term follow-up of the viability guided angioplasty after acute myocardial infarction (VIAMI) trial","volume":"186","author":"van Loon","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2024.12.004_bib57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1745-6215-14-218","article-title":"Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial","volume":"14","author":"O'Meara","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.hfc.2024.12.004_bib58","series-title":"Ischemia and viability imaging in heart failure: the alternative imaging modalities in ischemic heart failure trial (presented in late-breaking clinical trials)","author":"Mielniczuk","year":"2023"},{"key":"10.1016\/j.hfc.2024.12.004_bib59","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00006231-200306000-00003","article-title":"Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT","volume":"24","author":"Mabuchi","year":"2003","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.hfc.2024.12.004_bib60","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/01.CIR.0000142045.22628.74","article-title":"Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization","volume":"110","author":"Selvanayagam","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.12.004_bib61","doi-asserted-by":"crossref","first-page":"E668","DOI":"10.1002\/ccd.29888","article-title":"Viability and functional recovery after chronic total occlusion percutaneous coronary intervention","volume":"98","author":"Schumacher","year":"2021","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:05:27Z","timestamp":1750287927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1551713624001004"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.004","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viability and Congestive Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}